NICM
INSP icon

Neo Ivy Capital Management’s Inspire Medical Systems INSP Stock Holding History

Neo Ivy Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,688
Closed -$1.61M – 437
2025
Q3 		$1.61M Buy
21,688
+21,656
+67,675% +$2.19M 0.39% 91
2025
Q2 		$4.15K Buy
+32
New +$4.64K ﹤0.01% 335
2024
Q3 		– Sell
-21,296
Closed -$2.85M – 330
2024
Q2 		$2.85M Buy
+21,296
New +$4.03M 0.56% 100

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Neo Ivy Capital Management's INSP Position: Q4 2025 in Review

Neo Ivy Capital Management sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 21,688 shares — an estimated $1.61M sold.

Neo Ivy Capital Management first reported a position in INSP in Q2 2024 and held it in 3 quarters. The position peaked at $2.85M in Q2 2024. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • Neo Ivy Capital Management reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 21,688 Inspire Medical Systems shares in Q4 2025, an estimated $1.61M.
  • Neo Ivy Capital Management first reported a position in Inspire Medical Systems in Q2 2024 and held it in 3 quarters.
  • Neo Ivy Capital Management's Inspire Medical Systems position peaked at $2.85M in Q2 2024.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on Neo Ivy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.